These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 37770991)

  • 1. Long non-coding RNA MIDEAS-AS1 inhibits growth and metastasis of triple-negative breast cancer via transcriptionally activating NCALD.
    Luo D; Liang Y; Wang Y; Ye F; Jin Y; Li Y; Han D; Wang Z; Chen B; Zhao W; Wang L; Chen X; Jiang L; Yang Q
    Breast Cancer Res; 2023 Sep; 25(1):109. PubMed ID: 37770991
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CTCF-Induced lncRNA C5orf66-AS1 Facilitates the Progression of Triple-Negative Breast Cancer via Sponging miR-149-5p to Up-Regulate CTCF and CTNNB1 to Activate Wnt/β-Catenin Pathway.
    Zhu S; Sun J; Liu X; Shao H; Feng C; Wang Z; Zheng X; Wei S
    Mol Cell Biol; 2022 Jun; 42(6):e0018821. PubMed ID: 35499320
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long noncoding RNA ST8SIA6-AS1 promotes cell proliferation and metastasis in triple-negative breast cancer by targeting miR-145-5p/CDCA3 to inactivate the p53/p21 signaling pathway.
    Qiao Y; Wang B; Yan Y; Niu L
    Environ Toxicol; 2022 Oct; 37(10):2398-2411. PubMed ID: 35730485
    [TBL] [Abstract][Full Text] [Related]  

  • 4. LncRNA WEE2-AS1 promotes proliferation and inhibits apoptosis in triple negative breast cancer cells via regulating miR-32-5p/TOB1 axis.
    Wang R; Huang Z; Qian C; Wang M; Zheng Y; Jiang R; Yu C
    Biochem Biophys Res Commun; 2020 Jun; 526(4):1005-1012. PubMed ID: 32307083
    [TBL] [Abstract][Full Text] [Related]  

  • 5. LncRNA FAM83H-AS1 promotes triple-negative breast cancer progression by regulating the miR-136-5p/metadherin axis.
    Han C; Fu Y; Zeng N; Yin J; Li Q
    Aging (Albany NY); 2020 Feb; 12(4):3594-3616. PubMed ID: 32074085
    [TBL] [Abstract][Full Text] [Related]  

  • 6. LncRNA SEMA3B-AS1 inhibits breast cancer progression by targeting miR-3940/KLLN axis.
    Hu J; Huang H; Xi Z; Ma S; Ming J; Dong F; Guo H; Zhang H; Zhao E; Yao G; Yang L; Zhang F; Zheng W; Chen H; Huang T; Li L
    Cell Death Dis; 2022 Sep; 13(9):800. PubMed ID: 36123344
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel tumor suppressor ASMTL-AS1 regulates the miR-1228-3p/SOX17/β-catenin axis in triple-negative breast cancer.
    Sun J; Li X; Yu E; Liu J; Sun L; He Q; Lu Q
    Diagn Pathol; 2021 May; 16(1):45. PubMed ID: 34006305
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exploring the regulatory role of FBXL19-AS1 in triple-negative breast cancer through the miR-378a-3p/OTUB2 axis.
    Guo C; Zhang M; Jin X; Zhu C; Qian J; Tao M
    Cell Biochem Funct; 2024 Jun; 42(4):e4020. PubMed ID: 38702967
    [TBL] [Abstract][Full Text] [Related]  

  • 9. POU2F2-mediated upregulation of lncRNA
    Li J; Li PT; Wu W; Ding BN; Wen YG; Cai HL; Liu SX; Hong T; Zhang JF; Zhou JD; Qian LY; Du J
    Epigenomics; 2024 Feb; 16(4):215-231. PubMed ID: 38318853
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ZEB1 induced-upregulation of long noncoding RNA ZEB1-AS1 facilitates the progression of triple negative breast cancer by binding with ELAVL1 to maintain the stability of ZEB1 mRNA.
    Luo N; Zhang K; Li X; Hu Y
    J Cell Biochem; 2020 Oct; 121(10):4176-4187. PubMed ID: 31922280
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MYBL2-induced PITPNA-AS1 upregulates SIK2 to exert oncogenic function in triple-negative breast cancer through miR-520d-5p and DDX54.
    Liu B; Yao P; Xiao F; Guo J; Wu L; Yang Y
    J Transl Med; 2021 Aug; 19(1):333. PubMed ID: 34353336
    [TBL] [Abstract][Full Text] [Related]  

  • 12. lncRNA SEMA3B-AS1 Inhibits miR-513c-5p to Regulate the Progression of Triple-negative Breast Cancer.
    Yu H; Wu Y; Huang J; Li S
    Anticancer Res; 2023 Dec; 43(12):5475-5484. PubMed ID: 38030196
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long non-coding RNA ZEB2-AS1 promotes the proliferation, metastasis and epithelial mesenchymal transition in triple-negative breast cancer by epigenetically activating ZEB2.
    Zhang G; Li H; Sun R; Li P; Yang Z; Liu Y; Wang Z; Yang Y; Yin C
    J Cell Mol Med; 2019 May; 23(5):3271-3279. PubMed ID: 30825262
    [TBL] [Abstract][Full Text] [Related]  

  • 14. STAT3-induced HLA-F-AS1 promotes cell proliferation and stemness characteristics in triple negative breast cancer cells by upregulating TRABD.
    Wu D; Jia H; Zhang Z; Li S
    Bioorg Chem; 2021 Apr; 109():104722. PubMed ID: 33618253
    [TBL] [Abstract][Full Text] [Related]  

  • 15. LncRNA SLC16A1-AS1 regulates the miR-182/PDCD4 axis and inhibits the triple-negative breast cancer cell cycle.
    Jiang B; Liu Q; Gai J; Guan J; Li Q
    Immunopharmacol Immunotoxicol; 2022 Aug; 44(4):534-540. PubMed ID: 35316129
    [TBL] [Abstract][Full Text] [Related]  

  • 16. lncRNA AFAP1-AS1 promotes triple negative breast cancer cell proliferation and invasion via targeting miR-145 to regulate MTH1 expression.
    Zhang X; Zhou Y; Mao F; Lin Y; Shen S; Sun Q
    Sci Rep; 2020 May; 10(1):7662. PubMed ID: 32376943
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Formononetin relieves the facilitating effect of lncRNA AFAP1-AS1-miR-195/miR-545 axis on progression and chemo-resistance of triple-negative breast cancer.
    Wu J; Xu W; Ma L; Sheng J; Ye M; Chen H; Zhang Y; Wang B; Liao M; Meng T; Zhou Y; Chen H
    Aging (Albany NY); 2021 Jul; 13(14):18191-18222. PubMed ID: 34289449
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The circRNA circAGFG1 acts as a sponge of miR-195-5p to promote triple-negative breast cancer progression through regulating CCNE1 expression.
    Yang R; Xing L; Zheng X; Sun Y; Wang X; Chen J
    Mol Cancer; 2019 Jan; 18(1):4. PubMed ID: 30621700
    [TBL] [Abstract][Full Text] [Related]  

  • 19. LncRNA PSMA3-AS1 activates the progression of triple-negative breast cancer cells by blocking miR-186-5p-mediated PSME3 inhibition.
    Peng M; Yuan H
    Cell Mol Biol (Noisy-le-grand); 2023 Dec; 69(14):81-87. PubMed ID: 38279473
    [TBL] [Abstract][Full Text] [Related]  

  • 20. LncRNA SOX9-AS1 triggers a transcriptional program involved in lipid metabolic reprogramming, cell migration and invasion in triple-negative breast cancer.
    Cisneros-Villanueva M; Fonseca-Montaño MA; Ríos-Romero M; López-Camarillo C; Jiménez-Morales S; Langley E; Rosette-Rueda AS; Cedro-Tanda A; Hernández-Sotelo D; Hidalgo-Miranda A
    Sci Rep; 2024 Jan; 14(1):1483. PubMed ID: 38233470
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.